Literature DB >> 12584317

Persistent replication of hepatitis C virus replicons expressing the beta-lactamase reporter in subpopulations of highly permissive Huh7 cells.

Edward M Murray1, Jay A Grobler, Eric J Markel, Marco F Pagnoni, Giacomo Paonessa, Adam J Simon, Osvaldo A Flores.   

Abstract

Progress toward development of better therapies for the treatment of hepatitis C virus (HCV) infection has been hampered by poor understanding of HCV biology and the lack of biological assays suitable for drug screening. Here we describe a powerful HCV replication system that employs HCV replicons expressing the beta-lactamase reporter (bla replicons) and subpopulations of Huh7 cells that are more permissive (or "enhanced") to HCV replication than naïve Huh7 cells. Enhanced cells represent a small fraction of permissive cells present among naïve Huh7 cells that is enriched during selection with replicons expressing the neomycin phosphotransferase gene (neo replicons). The level of permissiveness of cell lines harboring neo replicons can vary greatly, and the enhanced phenotype is usually revealed upon removal of the neo replicon with inhibitors of HCV replication. Replicon removal is responsible for increased permissiveness, since this effect could be reproduced either with alpha interferon or with an HCV NS5B inhibitor. Moreover, adaptive mutations present in the replicon genome used during selection do not influence the permissiveness of the resulting enhanced-cell population, suggesting that the mechanisms governing the permissiveness of enhanced cells are independent from viral adaptation. Because the beta-lactamase reporter allows simultaneous quantitation of replicon-harboring cells and reporter activity, it was possible to investigate the relationship between genome replication activity and the frequency with which transfected genomes can establish persistent replication. Our study demonstrates that differences in the replication potential of the viral genome are manifested primarily in the frequency with which persistent replication is established but modestly affect the number of replicons observed per replicon-harboring cell. Replicon copy number was found to vary over a narrow range that may be defined by a minimal number required for persistent maintenance and a maximum that is limited by the availability of essential host factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12584317      PMCID: PMC149762          DOI: 10.1128/jvi.77.5.2928-2935.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism.

Authors:  C Wang; P Sarnow; A Siddiqui
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

Review 2.  Epidemiology of hepatitis C: geographic differences and temporal trends.

Authors:  A Wasley; M J Alter
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

3.  Effect of alpha interferon on the hepatitis C virus replicon.

Authors:  J T Guo; V V Bichko; C Seeger
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Authors:  Masanori Ikeda; MinKyung Yi; Kui Li; Stanley M Lemon
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  Internal ribosome entry site within hepatitis C virus RNA.

Authors:  K Tsukiyama-Kohara; N Iizuka; M Kohara; A Nomoto
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

6.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

7.  Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

Authors:  T Pietschmann; V Lohmann; G Rutter; K Kurpanek; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations.

Authors:  N Krieger; V Lohmann; R Bartenschlager
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

9.  Regulation of PKR and IRF-1 during hepatitis C virus RNA replication.

Authors:  Jill Pflugheber; Brenda Fredericksen; Rhea Sumpter; Chunfu Wang; Felecia Ware; Donald L Sodora; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

10.  Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons.

Authors:  Giovanna Mottola; Giorgia Cardinali; Alessandra Ceccacci; Caterina Trozzi; Linda Bartholomew; Maria Rosaria Torrisi; Emanuela Pedrazzini; Stefano Bonatti; Giovanni Migliaccio
Journal:  Virology       Date:  2002-02-01       Impact factor: 3.616

View more
  28 in total

1.  Selection of an optimal RNA transfection reagent and comparison to electroporation for the delivery of viral RNA.

Authors:  Gladys Gonzalez; Loretta Pfannes; Robert Brazas; Rob Striker
Journal:  J Virol Methods       Date:  2007-06-11       Impact factor: 2.014

2.  Ralf Bartenschlager, Charles Rice, and Michael Sofia are honored with the 2016 Lasker~DeBakey Clinical Medical Research Award.

Authors:  Corinne L Williams
Journal:  J Clin Invest       Date:  2016-09-13       Impact factor: 14.808

3.  Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.

Authors:  Takanobu Kato; Tomoko Date; Michiko Miyamoto; Masaya Sugiyama; Yasuhito Tanaka; Etsuro Orito; Tomoyoshi Ohno; Kanji Sugihara; Izumi Hasegawa; Kei Fujiwara; Kiyoaki Ito; Atsushi Ozasa; Masashi Mizokami; Takaji Wakita
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

4.  Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.

Authors:  Donald R O'Boyle; Peter T Nower; Julie A Lemm; Lourdes Valera; Jin-Hua Sun; Karen Rigat; Richard Colonno; Min Gao
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

Review 5.  Hepatitis C virus experimental model systems and antiviral drug research.

Authors:  Susan L Uprichard
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

6.  Novel robust hepatitis C virus mouse efficacy model.

Authors:  Qing Zhu; Yoko Oei; Dirk B Mendel; Evelyn N Garrett; Montesa B Patawaran; Paul W Hollenbach; Sharon L Aukerman; Amy J Weiner
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

7.  Development of a cell-based hepatitis C virus infection fluorescent resonance energy transfer assay for high-throughput antiviral compound screening.

Authors:  Xuemei Yu; Bruno Sainz; Susan L Uprichard
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

8.  Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line.

Authors:  Samir Ali; Charles Pellerin; Daniel Lamarre; George Kukolj
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Subgenomic HCV RNA replication and its localization in the nucleus of the infected cells.

Authors:  Zaki Monawar Eisa
Journal:  Saudi J Biol Sci       Date:  2011-02-03       Impact factor: 4.219

Review 10.  New hepatitis C virus drug discovery strategies and model systems.

Authors:  Snawar Hussain; Naina Barretto; Susan L Uprichard
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.